Protalix BioTherapeutics (PLX) Other Non-Current Liabilities (2011 - 2021)

Protalix BioTherapeutics' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $38000.0 for Q2 2021.

• In Q2 2021, Other Non-Current Liabilities fell 69.35% year-over-year to $38000.0; the TTM figure through Jun 2021 stood at $38000.0 (down 69.35% YoY), while the FY2020 annual figure was $51000.0, down 89.98% from the prior year.
• Other Non-Current Liabilities was $38000.0 for Q2 2021 at Protalix BioTherapeutics, up from $26000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $6.2 million in Q3 2018 to a low of $26000.0 in Q1 2021.
• Historically, Other Non-Current Liabilities has averaged $2.9 million across 5 years, with a median of $5.1 million in 2017.
• The sharpest annual moves came in 2017 and 2020: Other Non-Current Liabilities grew 17.44% in 2017, then tumbled 99.14% in 2020.
• A 5-year view of Other Non-Current Liabilities shows it stood at $5.1 million in 2017, then increased by 4.77% to $5.3 million in 2018, then tumbled by 90.38% to $509000.0 in 2019, then tumbled by 89.98% to $51000.0 in 2020, then decreased by 25.49% to $38000.0 in 2021.
• The last three Other Non-Current Liabilities figures came in at $38000.0 (Q2 2021), $26000.0 (Q1 2021), and $51000.0 (Q4 2020), per Business Quant data.